Oxcarbazepine Therapy for Complete Central Diabetes Insipidus.

Case Rep Nephrol Dial

aDepartment of Medicine, Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts, USA.

Published: January 2018

Oxcarbazepine and carbamazepine cause hyponatremia by unknown mechanisms. We describe a patient with complete central diabetes insipidus and seizures who developed worsening hyponatremia when her dose of oxcarbazepine was increased. The patient maintained a normal serum sodium level and has had appropriately concentrated urine for 5 years on just oxcarbazepine, despite undetectable antidiuretic hormone (ADH) levels. This suggests that oxcarbazepine (or one of its metabolites) may stimulate collecting tubule V2 receptor-G protein complex independent of ADH, resulting in increased renal tubular water reabsorption. Oxcarbazepine may be useful as an alternative therapy for patients with central diabetes insipidus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836185PMC
http://dx.doi.org/10.1159/000485244DOI Listing

Publication Analysis

Top Keywords

central diabetes
12
diabetes insipidus
12
complete central
8
oxcarbazepine
6
oxcarbazepine therapy
4
therapy complete
4
insipidus oxcarbazepine
4
oxcarbazepine carbamazepine
4
carbamazepine hyponatremia
4
hyponatremia unknown
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!